Sachin Sadekar is the valued leader of our India team. His experience and insights have been critical to the success of our Data and SaaS and BPaaS businesses as well as our Technology Innovation and M&A strategy. We are lucky to have him at the helm.
IntegriChain
Pharmaceutical Manufacturing
Philadelphia, PA 74,251 followers
Data-Driven Commercialization
About us
IntegriChain helps Pharma manufacturers bring their science to market, ensuring patients have affordable, timely, and sustainable access to therapy. We are doing this by building Pharma’s data-driven commercialization platform – from strategy to operational execution. Our unique focus on data, technology, consulting, and outsourcing helps connect the commercial, financial, and operational dimensions of drug access and profitability. IntegriChain enables pharmaceutical innovators to achieve better commercial outcomes by digitalizing daily and recurring business activities and by integrating data and operations across contracting, pricing, channel and distribution, and gross-to-net. We are backed by Nordic Capital, a leading sector-specialized private equity investor with a broad portfolio in Healthcare and Pharma. Additional companies in the IntegriChain family are Blue Fin Group, a leading strategy consultancy for the Pharma industry, and Federal Compliance Solutions, a leading Pharma advisory and managed services firm.
- Website
-
https://www.integrichain.com
External link for IntegriChain
- Industry
- Pharmaceutical Manufacturing
- Company size
- 501-1,000 employees
- Headquarters
- Philadelphia, PA
- Type
- Privately Held
- Founded
- 2005
- Specialties
- Life Sciences Channel Data and Analytics, Pharmaceutical Commercial Data Analytics, Business Intelligence, Advanced Analytics, Distribution Analytics, Patient Access, Market Access, Specialty Pharmaceuticals Analytics, Payer Analytics, Access Management, Government Pricing, Rebate Processing, Patient Services, Channel Data Aggregation, Inventory Analytics, Pharma Access, Pharma Distribution, Pharma Distribution Management, Master Data Management, Data Science, and Gross to net automation
Products
IntegriChain ICyte Platform
Pharmacy Management Systems
IntegriChain helps Pharma manufacturers bring their science to market, ensuring patients have affordable, timely, and sustainable access to therapy. We are doing this by building Pharma’s data-driven commercialization platform – from strategy to operational execution. Our unique focus on data, technology, consulting, and outsourcing helps connect the commercial, financial, and operational dimensions of drug access and profitability. IntegriChain enables pharmaceutical innovators to achieve better commercial outcomes by digitalizing daily and recurring business activities and by integrating data and operations across contracting, pricing, channel and distribution, and gross-to-net.
Locations
-
Primary
8 Penn Center
1628 JFK Boulevard
Philadelphia, PA 19103, US
-
201 S Maple St
Ambler, Pennsylvania 19002, US
-
Pancard Club Rd
M Agile, Samarth Colony
Baner Pune, Maharashtra 411045, IN
Employees at IntegriChain
-
Gary Palgon, CISSP
Sales. Marketing and Operations Executive; Healthcare/Life Sciences; Analytics/Security/Cloud
-
Michael Kerman
Marketing and Technology Executive | Revenue Generator | Talent Developer
-
David Weiss
-
Vickie Kozhushchenko
CHRO, delivering HR Strategy, Peer & Leadership Coaching, Org Dynamics and Transformation. I bring strategic HR thinking to private equity-backed…
Updates
-
Struggling to get patients to fill non-specialty drug prescriptions? Traditional pharmacies and current solutions may not be enough. Discover how to cap patient costs at $35 in our 3-part webinar series. In Part 1, Daniel Landis and Katie Herrick will focus on how manufacturers can combat these challenges. Join us on July 16: https://lnkd.in/e8mca4gD
-
We welcome Richard Moore, Jeff Blake, Nicholas Lynch, CFE, Walter Worsham and the entire Federal Compliance Solutions, an IntegriChain Company team to IntegriChain. Their expertise combined with our own William Roth, Jeffrey Baab, Jennifer Sharpe, MBA and their teams gives Pharma manufacturers a deep bench of expertise across hot topic areas such as 340B, fair market value, Medicare Part D redesign, state price transparency reporting (SPTR), payer economic models, and more. Additionally, FCS’ strong team of Managed Care, Medicaid, Government Pricing, and technology professionals reinforces our BPaaS & SaaS offerings by adding significant depth and breadth of expertise to help drive our innovation. We’re excited to join forces! Read more: https://bit.ly/4eSQOIp
-
IntegriChain reposted this
It brings me immense excitement to share the news of IntegriChain's acquisition of the BridgeView Life Sciences DataBridge and PatientBridge platforms. Our team and clients are now part of the IntegriChain family, marking the beginning of a new and exciting chapter. This acquisition underscores our commitment to providing innovative commercial and market access data platform solutions for our clients. BridgeView Life Sciences will continue to serve as a commercial consulting and services partner to Life Sciences companies and as a strategic partner to IntegriChain. For more insights on this significant milestone for BridgeView and IntegriChain, please don't hesitate to reach out to me. Michael Zubey CEO BridgeView Life Sciences Learn more: https://lnkd.in/en9D85UR
-
IntegriChain reposted this
We're excited to announce that Nordic Capital-backed IntegriChain has acquired Federal Compliance Solutions, an IntegriChain Company, assembling the industry's most comprehensive team of experts in government pricing and payer/provider contracting. This strategic move will bolster IntegriChain's capabilities in the dynamic regulatory landscape and deliver unparalleled value to pharmaceutical clients. Read the full press release here: https://lnkd.in/d2YRvSWe
-
IntegriChain reposted this
We are thrilled to announce that we’ve acquired Federal Compliance Solutions LLC! FCS’s domain knowledge and quality + IntegriChain’s data and tech innovation = the leading net revenue management outsourcing and consulting capability for the Pharma industry. We welcome Richard Moore, Jeff Blake, Nicholas Lynch, CFE, Walter Worsham and the entire FCS team. We’re excited to join forces, drive more profitable daily business decisioning, and accelerate our innovation. Read more: https://bit.ly/4eSQOIp
-
We are thrilled to announce that we’ve acquired Federal Compliance Solutions LLC! FCS’s domain knowledge and quality + IntegriChain’s data and tech innovation = the leading net revenue management outsourcing and consulting capability for the Pharma industry. We welcome Richard Moore, Jeff Blake, Nicholas Lynch, CFE, Walter Worsham and the entire FCS team. We’re excited to join forces, drive more profitable daily business decisioning, and accelerate our innovation. Read more: https://bit.ly/4eSQOIp
-
Discover actionable strategies, tactics, and industry benchmarks at the Access Insights Conference. Join IntegriChain and Blue Fin Group, an IntegriChain Company, from October 14-16 at the Mayflower Hotel. Secure your spot today: https://lnkd.in/eYB8irsw
-
Our own William Roth Roth weighs in on the state of the generics industry and the Medicare Drug Shortage Prevention and Mitigation Program proposed legislation in Pharmacy Practice News. Read his hot take: https://bit.ly/4eRSulB
-
Before the holiday weekend, check out the latest Industry Insights from Jennifer Sharpe, MBA, Jui Andhare, MBA and Jyoti Dubey here: https://bit.ly/4bsYsWW